Aggregate Safety Reporting

We compile and deliver safety reports, including IND Annual Reports, Clinical Study Reports, DSURs, ASRs, PSURs, PBRERs, PADERs, NDA, ANDA. Our services involve utilizing the PSO/ACO methodology for classification and rule discovery in postmarketing surveillance or pharmacovigilance.

This service meets the needs and obligations of the MAH surveillance team to comply with current legislation.

Don’t hesitate to contact us for more information.

Aggregate Safety Reporting - Services

Why is it important?

HOW WE CAN HELP YOU?

Vigilance is a key responsibility of the MAH and therefore our dedication is addressed to ensure the safety and efficacy of human health products, especially pharmaceuticals, throughout the product life cycle, from development to post-marketing”. 

The safety problems of pharmaceutical products are the most feared, along with those of manufacturing quality. They can lead to the withdrawal of a drug, the recall of a batch or even the recall of a producto.

Why QbD Group?

YOUR EXPERT IN AGGREGATE SAFETY REPORTING

With more than 10 years providing PV services, our experience ensures optimal compliance with national and international PV regulations. Following our commitment to quality, our PV activities are certified to ISO 9001:2015.

Tailored solutions

FLEXIBLE SERVICE

The actual approach of this service is up to you. It is fully tailored to your needs.

Contact us

TALK TO AN EXPERT

Don’t hesitate to contact us so we can listen to your needs and provide you with the right service.

Come visit our booth at CPHI Barcelona 2023

Come to see the QbD Group at stand #3G73 at CPHI Conference in Barcelona. And after the conference…Eat & Connect with lifescience professionals at our QbD’s CPHI Networking Drink.